Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90
- PMID: 18197612
- DOI: 10.1021/jm701385c
Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90
Abstract
Heat shock protein 90 (Hsp90) is a molecular chaperone that is responsible for activating many signaling proteins and is a promising target in tumor biology. We have identified small-molecule benzisoxazole derivatives as Hsp90 inhibitors. Crystallographic studies show that these compounds bind in the ATP binding pocket interacting with the Asp93. Structure based optimization led to the identification of potent analogues, such as 13, with good biochemical profiles.
Similar articles
-
Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90.Bioorg Med Chem Lett. 2008 Jun 15;18(12):3517-21. doi: 10.1016/j.bmcl.2008.05.023. Epub 2008 May 9. Bioorg Med Chem Lett. 2008. PMID: 18511277
-
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer.J Med Chem. 2008 Jan 24;51(2):196-218. doi: 10.1021/jm701018h. Epub 2007 Nov 20. J Med Chem. 2008. PMID: 18020435
-
Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90.J Med Chem. 2011 Dec 22;54(24):8592-604. doi: 10.1021/jm201155e. Epub 2011 Nov 23. J Med Chem. 2011. PMID: 22066525
-
Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.Curr Opin Investig Drugs. 2006 Jun;7(6):534-41. Curr Opin Investig Drugs. 2006. PMID: 16784024 Review.
-
Heat shock protein 90: a unique chemotherapeutic target.Semin Oncol. 2006 Aug;33(4):457-65. doi: 10.1053/j.seminoncol.2006.04.001. Semin Oncol. 2006. PMID: 16890800 Review.
Cited by
-
Novel N-(4,5,6,7-tetrahydrobenzisoxazol-4-yl)amides as HSP90 inhibitors: design, synthesis and biological evaluation.RSC Med Chem. 2025 Mar 28. doi: 10.1039/d4md00904e. Online ahead of print. RSC Med Chem. 2025. PMID: 40223823 Free PMC article.
-
Applications of palladium-catalyzed C-N cross-coupling reactions in pharmaceutical compounds.RSC Adv. 2023 Jun 20;13(27):18715-18733. doi: 10.1039/d2ra07412e. eCollection 2023 Jun 15. RSC Adv. 2023. PMID: 37346956 Free PMC article. Review.
-
Computational polypharmacology analysis of the heat shock protein 90 interactome.J Chem Inf Model. 2015 Mar 23;55(3):676-86. doi: 10.1021/ci5006959. Epub 2015 Feb 23. J Chem Inf Model. 2015. PMID: 25686391 Free PMC article.
-
Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.Expert Opin Drug Discov. 2011 May;6(5):559-587. doi: 10.1517/17460441.2011.563296. Expert Opin Drug Discov. 2011. PMID: 22400044 Free PMC article.
-
Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitors.J Mol Model. 2012 Nov;18(11):4843-63. doi: 10.1007/s00894-012-1479-z. Epub 2012 Jun 16. J Mol Model. 2012. PMID: 22707278
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information